Compound Detail
CHEMBL4647008
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4647008 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | TVFIFFUSHZDTKT-UHFFFAOYSA-N |
3
Targets
13
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
423.4
MW (Da)
2.69
ALogP
9
HBA
1
HBD
128.7
PSA (Ų)
0.28
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 13 meas. best 7.76
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D-423MG CHEMBL2366134 | IC50 | 7.76 | 7.0767 | 17.3 | 3 |
| Unchecked CHEMBL612545 | IC50 | 7.42 | 6.6325 | 38.0 | 4 |
| Alpha-enolase CHEMBL3298 | IC50 | 6.22 | 5.8233 | 604.0 | 6 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32676158 | 10.1021/acsmedchemlett.0c00203 | Alpha-enolase | 6 |
| 32676158 | 10.1021/acsmedchemlett.0c00203 | Unchecked | 3 |
| 36251833 | 10.1021/acs.jmedchem.2c01039 | D-423MG | 2 |
| 32676158 | 10.1021/acsmedchemlett.0c00203 | ADMET | 1 |
| 33130289 | 10.1016/j.bmcl.2020.127656 | D-423MG | 1 |
| 36251833 | 10.1021/acs.jmedchem.2c01039 | Unchecked | 1 |
| 36251833 | 10.1021/acs.jmedchem.2c01039 | Panel NCI-60 (60 carcinoma cell lines) | 1 |
| 36251833 | 10.1021/acs.jmedchem.2c01039 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine